View in EDS HTML Full Text PDF Full Text

Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes.

Saved in:

Bibliographic Details
Title:	Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes.
Authors:	Wang, Yan-Hua¹ (AUTHOR), Hagiwara, Shotaro¹ (AUTHOR), Kazama, Hiroshi^1,2 (AUTHOR), Iizuka, Yuki¹ (AUTHOR), Tanaka, Norina¹ (AUTHOR), Tanaka, Junji¹ (AUTHOR)
Source:	Journal of Immunology Research. 2/27/2024, Vol. 2024, p1-18. 18p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	23148861
DOI:	10.1155/2024/1429879